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http://dx.doi.org/10.1016/j.jfma.201
0929-6646/Copyright ª 2014, ElsevierBackground/Purpose: Sustained ventricular tachycardia and ventricular fibrillation (VT/VF)
are rare complications after coronary surgery. Off-pump coronary artery bypass (OPCAB)
was developed to decrease postoperative complications. No studies to date have specifically
addressed VT/VF after OPCAB. We sought to assess the incidence, risk factors, and outcome
of VT/VF after OPCAB.
Methods: The study included a retrospective reviewof 1010 patients undergoingOPCABbetween
2000 and 2012. Data were compared between the VT/VF patients and control patients who were
the first cases of OPCAB in each month during the study period and did not have VT/VF.
Results: Twenty-three patients (2.3%) developed VT/VF after OPCAB. The hospital mortality
rate was 17.4%. In univariate analysis, the risk factors for VT/VF were old age, rapid heart rate,
prolonged corrected QT interval, severe congestive heart failure, poor left ventricular ejection
fraction, large left ventricular end-diastolic diameter, chronic kidney disease, preoperative dial-
ysis, low blood hemoglobin level, preoperative intubation, recent myocardial infarction, high
European System for Cardiac Operative Risk Evaluation, urgent/emergent operation, use of
intra-aortic balloon pump, conversion to on-pump beating heart, postoperative dialysis, and
no use of beta-blockers after operation. Multivariate analysis identified preoperative corrected
QT interval > 426 milliseconds [odds ratio (OR)Z 4.501; 95% confidence interval (CI)Z 1.153
e17.570] and estimated glomerular filtration rate < 30 mL/minute/1.73 m2 (ORZ 4.876; 95%
CIZ 1.112e21.374) as independent risk factors.
Conclusion: Postoperative VT/VF was rare after OPCAB but was associated with high mortality.
Prolonged corrected QT interval and chronic kidney disease were independent risk factors.
Recognition of these risk factors, proper prevention, and early intervention may improve sur-
vival.
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Malignant ventricular arrhythmias, including sustained
ventricular tachycardia and ventricular fibrillation (VT/VF),
are rare but serious complications after coronary artery
bypass graft (CABG) surgery.1e8 Identification of the risk
factors and further preventive strategy are important for
patient survival. However, their mechanisms and clinical
implications remain uncertain. CABG is one of the most
common types of cardiac surgery performed in adult pa-
tients. It has traditionally been performed with the use of
cardiopulmonary bypass. Cardiopulmonary bypass has been
suggested to be related to the development of many
postoperative complications. The technique of operating
on a beating heart or off-pump coronary artery bypass
(OPCAB) was developed to decrease postoperative compli-
cations, some of which are related to the use of cardio-
pulmonary bypass.9 No studies to date have specifically
addressed the occurrence of VT/VF after OPCAB. The pur-
pose of this study was to assess the incidence, risk factors,
and outcome of VT/VF after OPCAB.Methods
Patients
This was a retrospective, observational, cohort study of
prospectively collected data. We included all consecutive
unselected patients who were planned to undergo OPCAB
performed by a single surgeon (Dr Hsu) between December
2000 and January 2012 at the National Taiwan University
Hospital. Patients simultaneously undergoing valvular or
aortic surgery were excluded. No patient with coronary
artery disease was excluded from the off-pump method
because of the pattern of coronary artery disease, presence
of cardiogenic shock, or emergency of surgery. Patients
with a previous history of VT/VF before OPCAB were
included.
The National Taiwan University Hospital is a 2200-bed
tertiary care hospital. It serves an urban population of 2
million as both first-line and tertiary facilities. It serves also
as a referral center for other hospitals in the country with a
population of 23 million people. All data were collected by
retrospective chart review. The local institutional medical
ethics committee approved the study and waived the need
for informed consent.
Operation
Beginning from December 2000, we stared a systematic
approach to treat all coronary artery disease patients with
OPCAB.10 The operation was performed through a median
sternotomy. The heparin dose is two-thirds of the standard
dose for cardiopulmonary bypass. The target-activated
clotting time is more than 400 seconds. This is partially
reversed with one-half of the calculated protamine dose
after the completion of coronary anastomosis. Cardiopul-
monary bypass was on standby without priming the pump.
Distal anastomoses were performed using a suction-type
coronary stabilizer and intracoronary shunt. Pericardialtraction suture and apical suction device were not used for
assistance. Only table tilting was used to help position the
heart.The usual order of bypass was anterior wall, posterior
wall, and lateral wall. The operation was converted to on-
pump beating heart CABG if there was hemodynamic
compromise during the procedure.11
Definition
The cases of VT/VF were defined as patients who required
advanced cardiac life support interventions to terminate
the malignant ventricular arrhythmia and to stabilize them
in the postoperative period before discharge.1e8,12 Sus-
tained VT was defined as a uniform tachyarrhythmia of
ventricular origin that had a duration > 20 seconds, unless
terminated early because of hemodynamic collapse.1e8 VT/
VF appearing after discharge was not included in this study.
Risk factor
During the study period, 134 patients who were the first
cases of OPCAB in each month by time line during the study
period and did not have VT/VF were selected as the control
patients. Data were compared between the study patients
and control patients.
Statistical analysis
SPSS 20.0 for Windows was used for analysis (SPSS Inc.,
Chicago, IL, USA). All data were presented in form of a
median with interquartile range. Differences between pa-
tients with and without postoperative VT/VF were analyzed
with Chi-square test for categorical variables and Man-
neWhitney U test for continuous variables. The diagnostic
cutoff value for continuous variables was calculated by
receiver-operating characteristic curves. The cutoff value
was used as a new categorical data. A multivariate logistic
regression analysis was performed on variables that were
considered as risk factors in the univariate analysis with
p < 0.05. When two or more risk factors in the same field
were strongly correlated, only one factor that most strongly
associated with VT/VF was retained in the final model. A p
value < 0.05 was considered statistically significant.
Follow-up information was obtained by chart review and
telephone contact. Survival in VT/VF patients was esti-
mated by the KaplaneMeier method.
Results
VT/VF
Twenty-three patients suffered VT/VF (2.3%) after OPCAB.
Patient characteristics are listed in Table 1. There were 19
men and four women with the median age of 71 years
(range: 44e90). Three patients (13%) had VT/VF before
operation. Nineteen patients had triple vessel disease, and
nine patients had significant left main disease. Seven
patients had impaired left ventricular ejection
fraction < 30%. Mode of surgical intervention was elective
in 10 patients, urgent in nine patients, and emergent in
















1 Male 76 2 0 45 1 0 Urgent 11 OPCAB Alive
2 Male 73 2 0 24 1 0 Emergency 15 Conversion Alive
3 Female 77 3 0 41 0 1 Elective 14 OPCAB Alive
4 Male 67 3 1 25 0 0 Emergency 16 Conversion Died of shock
5 Male 71 2 0 46 0 0 Urgent 12 Conversion Alive
6 Male 79 3 1 15 1 0 Elective 16 Conversion Alive
7 Male 44 3 0 17 1 0 Elective 8 OPCAB Alive
8 Male 61 3 0 35 0 0 Elective 4 OPCAB Alive
9 Female 69 3 0 46 0 0 Urgent 13 OPCAB Alive
10 Male 83 3 1 46 1 0 Elective 11 OPCAB Alive
11 Male 74 3 1 45 0 0 Elective 4 OPCAB Alive
12 Male 63 3 0 24 1 0 Elective 7 OPCAB Alive
13 Female 68 3 0 32 1 0 Elective 12 OPCAB Alive
14 Male 65 3 0 42 1 1 Emergency 14 Conversion Died of shock
15 Male 78 3 1 42 1 0 Elective 5 OPCAB Alive
16 Male 72 3 0 48 1 0 Elective 6 OPCAB Alive
17 Female 58 3 1 52 1 1 Urgent 12 OPCAB Died of ischemic
bowel
18 Male 88 3 0 20 0 0 Emergency 15 Conversion Died of shock
19 Male 75 3 1 30 1 0 Urgent 18 OPCAB Alive
20 Male 90 3 1 32 0 0 Urgent 13 OPCAB Alive
21 Male 66 3 1 62 0 0 Urgent 6 OPCAB Alive
22 Male 57 3 0 43 1 1 Urgent 9 OPCAB Alive
23 Male 69 2 0 29 0 0 Urgent 16 OPCAB Alive
DM Z diabetes mellitus; EuroSCORE Z European System for Cardiac Operative Risk Evaluation; LVEF Z left ventricular ejection
fraction; OPCAB Z off-pump coronary artery bypass.
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Operative Risk Evaluation (EuroSCORE) > 5 was present in
20 patients. The OPCAB was successfully performed in 17
cases. Operation was converted to on-pump beating heart
CABG in six cases (26%). The median onset time of VT/VF
was 2 days (range: <24 hours to 6 days) after operation.
The overall hospital mortality rate was 17.4% (4/23). The
causes of death were severe cardiogenic shock in three
patients and ischemic bowel in one patient. Follow up was
complete in all VT/VF patients. Implanted cardioverter
defibrillators were inserted in five patients. The mean
follow-up duration was 46.83  35.56 months. The 1- and
4-year KaplaneMeier survival rates were 78.3% and 71.7%,
respectively.
Risk factors
The receiver-operating characteristic curve analysis
showed that a cutoff value of the left ventricular ejection
fraction was 37%, of the left ventricular end-diastolic
diameter was 60 mm, of the preoperative electrocardio-
graphic corrected QT interval was 426 milliseconds, and of
the estimated glomerular filtration rate (eGFR) was 30 mL/
minute/1.73 m2 (Fig. 1). The predictive power of each
variable is shown in Table 2.
The clinical data of 23 VT/VF patients and 134 control
patients are listed in Tables 3 and 4. Patients with VT/VF
had a higher in-hospital mortality rate and a longer length
of hospital stay (Table 4). The univariate analysis showedseveral preoperative, operative, and postoperative factors
that were separately associated with a significant increase
in the prediction of VT/VF. The preoperative factors were
old age, rapid heart rate, prolonged corrected QT interval,
severe congestive heart failure, poor left ventricular
ejection fraction, large left ventricular end-diastolic
diameter, chronic kidney disease, preoperative dialysis,
low blood hemoglobin level, preoperative intubation,
recent myocardial infarction, and high EuroSCORE
(Table 3). The operative factors were urgent/emergent
operation, use of intra-aortic balloon pump, and conversion
to on-pump beating heart CABG. The postoperative factors
were postoperative dialysis and no use of beta-blockers
after operation (Table 4).
The multivariate logistic regression modeling identified
two preoperative factors that were independently associ-
ated with the risk of VT/VF: preoperative corrected QT
interval > 426 milliseconds [odds ratio (OR) Z 4.501; 95%
confidence interval (CI) Z 1.153e17.570; p Z 0.030] and
eGFR < 30 mL/minute/1.73 m2 (OR Z 4.876; 95%
CI Z 1.112e21.374; p Z 0.036).Discussion
VT/VFs are rare and represent the most serious arrhythmia
after CABG.1e8 Very few published data exist with respect
to the incidence and risk factors of VT/VF after OPCAB.3 To
the best of our knowledge, this is the first study specifically
Figure 1 Receiver-operating characteristic curve analysis for risk factors. AUC Z area under the curve; eGFR Z estimated
glomerular filtration rate; LVEDD Z left ventricular end-diastolic diameter; LVEF Z left ventricular ejection fraction;
ROC Z receiver-operating characteristic curve.
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dence of VT/VF after OPCAB was 2.3%. The annual inci-
dence ranged from 0% to 7.1% during the study years: 0% in
2001, 7.1% in 2002, 2.2% in 2003, 2.5% in 2004, 3.7% in 2005,Table 2 Specificity, sensitivity, and predictive values of
different data: user receiver-operating characteristic curve
to find cutoff point for selecting patient with high risk for
postoperative malignant ventricular arrhythmias.
Variables Sensitivity Specificity PPV NPV
LVEF < 37% 48 82 32 90
eGFR<30 mL/
min/1.73 m2
44 92 50 91
Corrected QT
interval > 426 ms
83 62 27 95
LVEDD > 60 mm 26 92 35 88
eGFR Z estimated glomerular filtration rate; LVEDD Z left
ventricular end-diastolic diameter; LVEF Z left ventricular
ejection fraction; NPV Z negative predictive value;
PPV Z positive predictive value.0% in 2006, 1.4% in 2007, 1.1% in 2008, 2.6% in 2009, 0.9% in
2010, and 2.9% in 2011. The risk factors of postoperative
VT/VF in the setting of OPCAB were identical to those who
underwent conventional on-pump CABG.1e8 Here, we
further identified two independent risk factors: preopera-
tive QTc interval > 426 milliseconds and eGFR < 30 mL/
minute/1.73 m2.
VT/VF occurs rarely after CABG with an incidence of
0.41e8.9%.1e8 In addition, the mortality rate ranges from
8% to 27%. VT/VF usually occurs unexpectedly anytime
after CABG. The pathogenesis of VT/VF after CABG involves
several factors, including myocardial ischemia or infarc-
tion, low cardiac output, drugs, and electrolyte distur-
bance. Many VT/VF patients have myocardial infarctions
and compromised heart function. Post-CABG VT/VF tends
to be recurrent and difficult to treat. The majority of pa-
tients had multiple recurrences in the first few hours and
days after the initial event. The current evidence base and
guidelines suggest that implantable cardioverter de-
fibrillators should be considered for all patients with left
ventricular ejection fraction  30e40% and receiving
optimal medical management.7,8 Our single-center,
Table 3 Preoperative characteristics in patients with and without malignant ventricular arrhythmia after systematic off-pump
coronary artery bypass.
Variables Without (n Z 134) With (n Z 23) p
Male 108 (81%) 19 (83%) 0.999
Age (y) 67 (57, 73) 71 (65, 77) 0.028
Body mass index 24.5 (22.6, 27.0) 24.2 (20.0, 25.8) 0.140
Diabetes mellitus 61 (46%) 13 (57%) 0.329
Hypertension 88 (66%) 20 (87%) 0.051
Chronic lung disease 9 (7%) 1 (4%) 0.999
Peripheral artery disease 17 (13%) 4 (17%) 0.515
Old stroke 14 (10%) 5 (22%) 0.125
End-stage renal disease with dialysis 4 (3%) 4 (17%) 0.017
Serum level of blood urea nitrogen (mg/dL) 18.3 (13.9, 24.7) 25.1 (39.1, 17.1) 0.011
Serum level of creatinine (mg/dL) 1.1 (0.9, 1.4) 1.4 (1.2, 3.6) 0.017
eGFR (mL/minute/1.73 m2) 57.4 (45.9, 74.4) 36.2 (12.7, 59.6) <0.001
eGFR<30 mL/minute/1.73 m2 10 (7.5%) 10 (43.5%) <0.001
Blood hemoglobin (mg/dL) 13.6 (11.9, 14.7) 11.7 (10.1, 13.3) <0.001
NYHA FC IV
III 17 (12.7%) 7 (30.4%) 0.061
IV 9 (6.7%) 7 (30.4%) <0.001
Electrocardiogram
Heart rate/minute 72 (65, 85) 80 (69, 96) 0.022
Corrected QT interval in ms 416 (393, 443) 451 (430, 476) <0.001
Corrected QT interval > 426 ms 51 (38.3%) 19 (82.6%) <0.001
Echocardiography
Left ventricular ejection fraction 56 (41, 65) 41 (29, 46) <0.001
Left ventricular ejection fraction < 37% 23 (17.8%) 11 (47.8%) <0.001
Left ventricular end-diastolic diameter (mm) 50 (45, 55) 53 (50, 61) 0.016
Left ventricular end-diastolic diameter > 60 mm 11 (8.2%) 6 (26.1%) 0.013
Apical aneurysm 1 (1%) 1 (4%) 0.274
Recent myocardial infarction 43 (31.3%) 16 (69.6%) 0.001
Previous myocardial infarction
Anterior wall 24 (18%) 9 (39%) 0.022
Lateral wall 14 (11%) 2 (9%) 0.999
Inferior wall 18 (14%) 7 (30%) 0.041
Diseased coronary artery
Left main 52 (39%) 9 (39%) 0.999
Left anterior descending 127 (95%) 22 (96%) 0.999
Left circumflex 122 (91%) 21 (91%) 0.999
Right coronary artery 121 (90%) 22 (96%) 0.695
Endotracheal intubation before operation 6 (4%) 4 (17%) 0.041
Ventricular arrhythmia before operation 5 (4%) 3 (13%) 0.094
EuroSCORE
Additive 4 (2, 7) 12 (7, 15) <0.001
Logistic 3.1 (1.5, 8.7) 30.8 (7.9, 55.9) <0.001
eGFR Z estimated glomerular filtration rate; EuroSCORE Z European System for Cardiac Operative Risk Evaluation; NYHA FC Z New
York Heart Association Functional Class.
All data are presented as n (%) or median (interquartile range).
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found that VT/VF complications were infrequent. Our
incidence of 2.3% was similar to the results reported in
previous studies.1e8
The theoretical benefits of OPCAB were avoidance of
cardiopulmonary bypass and myocardial ischemia. Post-
operative VT/VF is thought to be closely linked to periop-
erative myocardial ischemia or infarction. However, the
effect of OPCAB on postoperative VT/VF remains unclear.
In CABG, the myocardial injury as assessed by postoperative
release of cardiac enzymes was significantly reduced inOPCAB.13,14 Nevertheless, the effect of reduced myocardial
injury in OPCAB might be counterbalanced by a high rate of
fewer coronary anastomoses and incomplete revasculari-
zation associated with OPCAB.15 Ascione et al have
demonstrated that among 1135 OPCAB patients, 12 (1%) had
VT/VF after operation. The OPCAB was associated with a
substantial but nonsignificant protective effect against VT/
VF.3 However, this incidence might be underestimated
because patient selection bias existed. Not all coronary
patients were treated with OPCAB. Certain high-risk pa-
tients, such as those with diffuse coronary artery disease,
Table 4 Operative and postoperative characteristics in patients with and without malignant ventricular arrhythmia after
systematic off-pump coronary artery bypass.
Variables Without (n Z 134) With (n Z 23) p
Mode of intervention <0.001
Elective 110 (82.1%) 10 (43.5%)
Urgent 16 (11.9%) 9 (39.1%)
Emergency 9 (6.7%) 4 (17.4%)
Number of distal anastomoses 3 (3, 4) 3 (3, 4) 0.530
Use of internal mammary artery 127 (95%) 20 (87%) 0.165
Use of intra-aortic balloon pump 12 (9%) 10 (43%) <0.001
Conversion to on-pump beating heart 7 (5%) 6 (26%) <0.001
Postoperative cardiac enzymes
CK-MB at Day 1 12.4 (8, 18.8) 14.9 (9.8, 49.8) 0.229
CK-MB/CK ratio at Day 1 (%) 8.5 (6.0, 10.9) 7.4 (5.4, 10.1) 0.831
CK-MB at Day 2 13.4 (9.1, 24.0) 15.6 (11.7, 62.2) 0.203
CK-MB/CK ratio at Day 2 (%) 3.0 (2.2, 4.4) 3.3 (2.4, 7.4) 0.077
CK-MB at Day 3 13.0 (7.5, 18.2) 18.4 (9.9, 36.1) 0.105
CK-MB/CK ratio at Day 3 (%) 2.8 (1.9, 3.7) 3.1 (2.1, 5.5) 0.129
Postoperative dialysis 4 (3%) 7 (30.4%) <0.001
Atrial fibrillation 46 (34%) 7 (30%) 0.715
Reoperation for bleeding 3 (2%) 0 (0%) > 0.99
Mediastinitis 0 (0%) 0 (0%) > 0.99
Use of digitalis 27 (20%) 3 (13%) 0.571
Use of beta-blockers 73 (54%) 6 (26%) 0.012
Use of implantable cardioverter defibrillators 0 (0%) 5 (22%) <0.001
Length of hospital stay (d) 13 (11, 15) 15 (14, 23) 0.001
In-hospital mortality 3 (2.2%) 4 (17.4%) 0.009
CK Z creatine kinase.
All data are presented as n (%) or median (interquartile range).
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acute myocardial infarction were excluded in the majority
of previous OPCAB studies.15,16 These high-risk patients
were at high risk of developing VT/VF postoperatively.1e8
Our single-center, retrospective study of OPCAB in
consecutive and nonselected patients found that the post-
operative VT/VF incidence was 2.3%, which was not lower
than the rates reported in previous studies of conventional
on-pump CABG.1e8
Several perioperative factors have been reported to be
potentially associated with VT/VF after CABG, but the re-
sults are conflicting.1e8 However, even with over 10,000
patients, the power of the analysis was limited because of
the rarity of VT/VF. The reported risk factors were low left
ventricular ejection fraction, perioperative myocardial
infarction, and abnormal electrocardiogram. The largest
series to date were from a retrospective study involving
4411 patients undergoing CABG,3 and VT/VF occurred in 69
patients (1.6%). The risk factors were age < 65 years, fe-
male sex, body mass index < 25 kg/m2, unstable angina,
low left ventricular ejection fraction, the need of ino-
tropes, and use of intra-aortic balloon pump. However,
renal function was not evaluated. In this study, we tried to
perform an extensive multivariate analysis including
several previously identified risk factors. However, only two
of them appeared significantly related to postoperative VT/
VF onset: corrected QT interval > 426 milliseconds and
eGFR < 30 mL/minute/1.73 m2. It has been reported that
corrected QT interval was a marker of life-threatening
ventricular arrhythmias in patients after myocardialinfarction.17,18 Here, we further identified chronic kidney
disease (eGFR < 30 mL/minute/1.73 m2) as one of the in-
dependent risk factors for VT/VF. This finding is quite
interesting, as no similar result is reported in the literature.
Chronic kidney disease has been linked to serious ar-
rhythmias. Chronic renal disease has been reported to be
one of major predictors for early VT/VF after acute
myocardial infarction.19,20 In addition, chronic kidney dis-
ease was associated with a high risk of mortality in patients
with implantable cardioverter defibrillators or established
cardiovascular diseases.21,22 Proportionately more patients
with chronic kidney disease died from arrhythmia than
those without.21 Previous studies have shown an indepen-
dent relationship between worsened renal function and
atrial fibrillation, heart block, VT, VF, and asystole.23
Therefore, we believed that chronic kidney disease also
played an important role in the pathogenesis of VT/VF after
OPCAB. Further investigation is needed to determine
whether prevention, early detection, and more aggressive
intervention in the treatment of chronic kidney disease will
reduce the incidence of VT/VF in this population. Preven-
tive strategies are meticulous management of electrolytes,
early dialysis, and when indicated, early implantable car-
dioverter defibrillators.24,25
Several limitations of our study should be recognized.
First, the study population was small, the follow-up dura-
tion was short, the occurrence of VT/VF was infrequent,
and hence, we could not properly examine the independent
risk factors of VT/VF in the setting of OPCAB. Second, none
of our patients had continuous electrocardiographic
942 J.-W. Chen et al.monitoring during the hospital course, and thus only clini-
cally significant episodes of VT/VF were included in this
study. Third, the long-term follow-up data were lacking.
Some life-threatening VT/VF would occur after discharge.
Forth, we selected one case per month by time line as the
control group and certain selection bias may exist. How-
ever, this is the first study addressing the incidence, risk
factors, and outcome of VT/VF after OPCAB. Methods to
identify patients at high risk of developing VT/VF are of
important clinical implications. Although there was no ev-
idence of improved survival among coronary patients with a
depressed left ventricular ejection fraction and an
abnormal signal-averaged electrocardiogram in whom a
defibrillator was implanted prophylactically at the time of
CABG,24,25 our data provided two additional risk factors for
postoperative VT/VF. This study provided a basis of early
prophylactic implantable cardioverter defibrillators in more
selected patients at high risks for VT/VF after OPCAB.
Conclusion
Postoperative VT/VF was rare after OPCAB; however, when
occurring, it is associated with high mortality. Prolonged
corrected QT interval and chronic kidney disease were inde-
pendent risk factors. Recognition of these risk factors, proper
prevention, and early intervention may improve survival.
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